{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.0","upperLimit":"0.0","value":"0.0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"}],"units":"Participants"}],"description":"Blood samples were collected at baseline (Day 1, pre-dose) and on Day 29, and hemoglobin electrophoresis used, to measure the change from baseline in hemoglobin subtype C following a single dose of sotatercept.","dispersionType":"Full Range","groups":[{"description":"Participants received a single 35 mg dose of sotatercept by subcutaneous (SC) injection on Day 1, Day 43, and Day 85.","id":"OG000","title":"Sotatercept"}],"paramType":"MEAN","populationDescription":"All participants who received at least one dose of study treatment and had data for Change from Baseline in Hemoglobin Subtype C Following a Single Dose of Sotatercept","reportingStatus":"POSTED","timeFrame":"Baseline (Day 1, pre-dose) and Day 29","title":"Change From Baseline in Hemoglobin Subtype C Following a Single Dose of Sotatercept","type":"SECONDARY","unitOfMeasure":"Percentage of hemoglobin subtype C"}